Overview
Background
David graduated from the University of London with a BSc (Hons) in biochemistry (King’s College) and PhD which investigated the role of epidermal growth factor receptors in liver regeneration (Imperial College). Since then he has worked on a variety of projects including; immunoassay development (Ortho Clinical Diagnostics); artificial liver machine development (Imperial College); and p53 mutations in liver cancer (QIMR). He joined the Department of Nephrology at the Princess Alexandra Hospital in Brisbane in 1999. He is a senior lecturer in The University of Queensland Faculty of Medicine, a senior member of the UQ Kidney Disease Research Laboratory and manages the Princess Alexandra Hospital Endotoxin Testing Service.
His main research interests are in the area of renal tubulointerstitial fibrosis, inflammation and also the mechanisms of renal cancer development – particularly the role that cytokines and growth factors play in these processes. Current projects include the role of protease activated receptor-2 in renal scarring, inflammation and cancer, the mechanism of heavy metal toxicity in the kidney and the renoprotective properties of erythropoietin. The Princess Alexandra Hospital Endotoxin Testing Service routinely tests samples from dialysis units throughout Queensland.
Availability
- Associate Professor David Vesey is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Biochemistry, King's College London
- Doctor of Philosophy of Gastroenterology and Hepatology, Imperial College London
Works
Search Professor David Vesey’s works on UQ eSpace
2007
Journal Article
Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research)
Qi, Weier, Johnson, David W., Vesey, David A., Pollock, Carol A. and Chen, Xinming (2007). Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology, 12 (2), 155-159. doi: 10.1111/j.1440-1797.2007.00779.x
2007
Journal Article
Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3
Cheung, Catherine W., Vesey, David A., Nicol, David L. and Johnson, David W. (2007). Silibinin inhibits renal cell carcinoma via mechanisms that are independent if insulin-like growth factor-binding protein 3. BJU International, 99 (2), 454-460. doi: 10.1111/j.1464-410X.2007.06571.x
2007
Journal Article
Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney
Vesey, David A., Hooper, John D., Gobe, Glenda C. and Johnson, David W. (2007). Potential physiological and pathophysiological roles for protease-activated receptor-2 in the kidney. Nephrology, 12 (1), 36-43. doi: 10.1111/j.1440-1797.2006.00746.x
2007
Conference Publication
The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy
Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia:
2007
Conference Publication
The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy
Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. World Congress of Nephrology, Rio De Janeiro, Brazil, 21-25 April , 2007. International Society of Nephrology (ISN).
2007
Conference Publication
Erythropoietin: Novel applications beyond anaemia treatment
Vesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007.
2006
Journal Article
Novel renoprotective actions of erythropoietin: New uses for an old hormone
Johnson, David W., Forman, Colin and Vesey, David A. (2006). Novel renoprotective actions of erythropoietin: New uses for an old hormone. Nephrology, 11 (4), 306-312. doi: 10.1111/j.1440-1797.2006.00585.x
2006
Journal Article
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure
Johnson, D. W., Pat, B., Vesey, D. A., Guan, Z., Endre, Z. and Gobe, G. C. (2006). Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney International, 69 (10), 1806-1813. doi: 10.1038/sj.ki.5000356
2006
Conference Publication
PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells
Li, Jun, Vesey, David and Gobe, Glenda (2006). PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells. American Society of Nephrology Renal Research Week, San Diego, USA, 2006. ASN.
2006
Conference Publication
Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways
Rajandram, R ., Pat, B., Li, J., Percy, C. J., Vesey, D., Johnson, D. W. and Gobe, G. C. (2006). Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways. Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Melbourne, Australia, 14-18 August 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2006.00656.x
2006
Conference Publication
PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses
Gobe, G. C., Johnson, D. W., Kruger, W., Poronnik, P. and Vesey, D. A. (2006). PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses. Renal Week 2006: American Society of Nephrology Annual Meeting, San Diego, California, U.S., 14 - 19 November, 2006. American Society of Nephrology.
2006
Conference Publication
PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells
Li, J., Vesey, D. and Gobe, G. (2006). PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells. Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14–19 August 2006.
2006
Conference Publication
Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress
Yamada, M., Vesey, D., Johnson, D. W. and Gobe, G. (2006). Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress. ANZSN 2006: 42nd Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14-19 August 2006. Carlton, Vic., Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2006.00656.x
2005
Journal Article
Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells
Vesey, David A., Cheung, Catherine W., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda and Johnson, David W. (2005). Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. Kidney International, 67 (4), 1315-1329. doi: 10.1111/j.1523-1755.2005.00209.x
2005
Journal Article
Role of protein kinase C and oxidative stress in interleukin-1β-induced human proximal tubule cell injury and fibrogenesis
Vesey, David A., Cheung, Catherine, Endre, Zoltan, Gobe, Glenda and Johnson, David W. (2005). Role of protein kinase C and oxidative stress in interleukin-1β-induced human proximal tubule cell injury and fibrogenesis. Nephrology, 10 (1), 73-80. doi: 10.1111/j.1440-1797.2005.00363.x
2005
Conference Publication
PAR-2 activation promotes cortical fibroblast proliferation and matrix protein production: A potential role for locally expressed trypsinogen
Vesey, D., Kruger, W., Poronnik, P., Gobe, G. and Johnson, D. (2005). PAR-2 activation promotes cortical fibroblast proliferation and matrix protein production: A potential role for locally expressed trypsinogen. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x
2005
Conference Publication
Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas
Gobe, G., Li, J., Pat, B., Yan, J., Vesey, D., Johnson, D. and Nicol, D. (2005). Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, 4-8 September 2005, Carlton, Victoria. Blackwell Science: 1320-5358 (print); 1440-1797 (electronic). doi: 10.1111/j.1440-1797.2005.00461.x
2005
Conference Publication
Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of IGFBP-3 levels
Vesey, D., Cheung, C., Taylor, P., Kirkpatirick, C., Gobe, G., Winterford, C., Nicol, D. and Johnson, D. (2005). Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of IGFBP-3 levels. 41st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Victoria: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x
2005
Conference Publication
Cell death in the renal vascular endothelium: an analysis of cytoprotection by erythropoietin
Yamada, M., Pat, B., Vesey, D., Johnson, D. and Gobe, G. (2005). Cell death in the renal vascular endothelium: an analysis of cytoprotection by erythropoietin. 5th Annual Health and Medical Research Conference of Queensland, Brisbane, Queensland, 3-4 November 2005.
2005
Conference Publication
Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin
Gobe, G., Yamada, M., Pat, B., Vesey, D. and Johnson, D. W. (2005). Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x
Funding
Past funding
Supervision
Availability
- Associate Professor David Vesey is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Exploring Magnetic Resonance for Differentiating between Progressive and Non-Progressive Chronic Kidney Disease
Associate Advisor
Other advisors: Dr Robert Ellis, Associate Professor Ross Francis
-
Doctor Philosophy
Exploring Magnetic Resonance for Differentiating between Progressive and Non-Progressive Chronic Kidney Disease
Associate Advisor
Other advisors: Associate Professor Ross Francis, Dr Robert Ellis
Completed supervision
-
2021
Doctor Philosophy
Clinical Biobanking and the Distinguishing Risk of Progressive Chronic Kidney Disease Study
Associate Advisor
-
2020
Doctor Philosophy
Exploring Resistance of Renal Cell Carcinoma to Sunitinib Therapy
Associate Advisor
Other advisors: Professor Hemamali Samaratunga
-
2020
Doctor Philosophy
The role of the adipose tissue microenvironment in kidney cancer
Associate Advisor
Other advisors: Professor David Johnson
-
2016
Doctor Philosophy
Bioactive compounds from Australian Blacklip Abalone (Haliotis rubra) processing waste
Associate Advisor
-
2009
Doctor Philosophy
Targeting genes for identification and treatment of renal cell carcinoma
Associate Advisor
Other advisors: Professor David Johnson
Media
Enquiries
For media enquiries about Associate Professor David Vesey's areas of expertise, story ideas and help finding experts, contact our Media team: